Ignite Creation Date:
2024-07-17 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 3:33 PM
Study NCT ID:
NCT06479798
Status:
COMPLETED
Last Update Posted:
2024-06-28
First Post:
2024-06-22
Brief Title:
Accuracy of Convex Probe EBUS-TBNA Versus FDG-PETCT Imaging in Diagnosis and Staging of Lung Malignancies
Sponsor:
Ain Shams University
Organization:
Ain Shams University
Study Overview
Official Title:
Accuracy of Convex Probe EBUS-TBNA Versus FDG-PETCT Imaging in Diagnosis of Suspected Lung Cancer Staging of Concurrent Mediastinal Lymphadenopathy at Ain-Shams University Hospitals
Status:
COMPLETED
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Lung cancer is a prevalent cause of cancer-related mortality on a global scale Appropriate staging of lung cancer is of paramount importance as it customizes treatment and predicts prognosis Fludeoxyglucose-18 FDG positron emission tomography PET combined with low dose contrast computed tomography CT and endobronchial ultrasound-guided transbronchial needle aspiration EBUS-TBNA are two diagnostic modalities widely used in the field of staging diagnosis of lung malignancies the former depends on image analysis while the later enables real-time sampling of lymph nodes under sonographic guidance with concurrent cytological examination The present research aims to compare the diagnostic and staging accuracies of EBUS-TBNA versus FDG-PET CT as two diagnostic modalities in patients with suspected lung malignancies However as a secondary outcome this study aims at monitoring the possible complications arising post EBUS-TBNA procedure
Detailed Description:
Lung cancer is a prevalent cause of cancer-related mortality on a global scale Appropriate staging of lung cancer is of paramount importance as it customizes treatment and predicts prognosis Fludeoxyglucose-18 FDG positron emission tomography PET combined with low dose contrast computed tomography CT and endobronchial ultrasound-guided transbronchial needle aspiration EBUS-TBNA are two diagnostic modalities widely used in the field of staging diagnosis of lung malignancies the former depends on image analysis while the later enables real-time sampling of lymph nodes under sonographic guidance with concurrent cytological examination
Objective To compare the diagnostic and staging accuracy of convex probe EBUS-TBNA versus FDG - PETCT as two diagnostic modalities in diagnosis of suspected lung cancer staging of concurrent mediastinal lymphadenopathy Patients and Methods This prospective interventional cohort research was performed on 40 cases with suspected lung malignancies All cases were examined via FDG-PETCT followed by convex probe EBUS-TBNA for diagnosis of suspected lung cancer staging of concurrent mediastinal lymphadenopathy
Objective To compare the diagnostic and staging accuracy of convex probe EBUS-TBNA versus FDG - PETCT as two diagnostic modalities in diagnosis of suspected lung cancer staging of concurrent mediastinal lymphadenopathy Patients and Methods This prospective interventional cohort research was performed on 40 cases with suspected lung malignancies All cases were examined via FDG-PETCT followed by convex probe EBUS-TBNA for diagnosis of suspected lung cancer staging of concurrent mediastinal lymphadenopathy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None